Australian Drug Discovery Company AdAlta, Announces IPO to Accelerate New Therapies for Lung Fibrosis
Melbourne, Australia, July 8, 2016 / B3C newswire / -- AdAlta Limited, the biotechnology company specialising in the discovery and development of protein based therapeutics is seeking to raise up to AU$10 million in an initial public offering (IPO) on the …